Search research articles
Contact Us
Filters
Showing results (321-330 of 366) with videos related to
Page
of 37
Sort By:
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Molecular Metabolism
|
November 1, 2019
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
Pablo Fernández-Tussy, David Fernández-Ramos, Fernando Lopitz-Otsoa, et al.
Cell Death & Disease
|
September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
David Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology
|
May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
Paula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Nature Communications
|
December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Lucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Gastroenterologia Y Hepatologia
|
April 11, 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Rocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
JHEP Reports : Innovation in Hepatology
|
October 16, 2025
Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis
Álvaro Díaz-González, Ida Schregel, Lorena Carballo, et al.
Gastroenterology
|
January 31, 2017
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso, David Fernández-Ramos, Marta Varela-Rey, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 366) with videos related to
Sort By:
Page
of 37
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Molecular Metabolism
|
November 1, 2019
miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
Pablo Fernández-Tussy, David Fernández-Ramos, Fernando Lopitz-Otsoa, et al.
Cell Death & Disease
|
September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
David Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology
|
May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
Paula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 25, 2021
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Nature Communications
|
December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Lucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Gastroenterologia Y Hepatologia
|
April 11, 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Rocío Aller, Conrado Fernández-Rodríguez, Oreste Lo Iacono, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
JHEP Reports : Innovation in Hepatology
|
October 16, 2025
Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis
Álvaro Díaz-González, Ida Schregel, Lorena Carballo, et al.
Gastroenterology
|
January 31, 2017
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso, David Fernández-Ramos, Marta Varela-Rey, et al.
Page
of 37